Istikharah Rochmy, Nugrahaningsih Dwi Aris Agung, Sadewa Ahmad Hamim, Wahyuningsih Mae Sri Hartati
Department of Pharmacy, Universitas Islam Indonesia, Yogyakarta, Indonesia.
Doctoral candidate, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Malays J Med Sci. 2022 Jun;29(3):43-53. doi: 10.21315/mjms2022.29.3.5. Epub 2022 Jun 28.
In this study, we examined the anti-diabetic activity of standardised extracts of (Hemsley) A Gray () leaves for their effects on insulin resistance and mitochondrial DNA (mtDNA) copy number.
leaves were extracted using an ultrasound-assisted method and standardised using Tagitinin C. There were six groups: i) normal control; ii) diabetic group; iii) metformin group (300 mg/kg) and iv) groups treated with three different doses of extract (50 mg/kg, 100 mg/kg and 150 mg/kg). Blood samples were taken before and after 28 days of treatment for fasting plasma glucose (FPG) and insulin analysis, which were used for a Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) calculation. The soleus and gastrocnemius muscles were harvested after 28 days of treatment for the measurement of mtDNA copy number.
The results showed an improvement in blood glucose levels and HOMA-IR scores in all treatment groups. The results of mtDNA copy number analysis also revealed significant improvement with the highest number observed at an extract dose of 100 mg/kg in which the mtDNA copy number increased up to 3 times in the soleus muscles ( < 0.001).
extract has the potential to be used as an anti-diabetic agent that improves insulin resistance, possibly by increasing mtDNA content.
在本研究中,我们检测了(赫姆斯利)A·格雷()叶的标准化提取物对胰岛素抵抗和线粒体DNA(mtDNA)拷贝数的抗糖尿病活性。
采用超声辅助法提取叶,并使用塔吉替宁C进行标准化。共有六组:i)正常对照组;ii)糖尿病组;iii)二甲双胍组(300毫克/千克)和iv)用三种不同剂量提取物(50毫克/千克、100毫克/千克和150毫克/千克)处理的组。在治疗28天前后采集血样进行空腹血糖(FPG)和胰岛素分析,用于胰岛素抵抗稳态模型评估(HOMA-IR)计算。治疗28天后采集比目鱼肌和腓肠肌用于测量mtDNA拷贝数。
结果显示所有治疗组的血糖水平和HOMA-IR评分均有所改善。mtDNA拷贝数分析结果也显示出显著改善,在提取物剂量为100毫克/千克时观察到最高数量,其中比目鱼肌中的mtDNA拷贝数增加了高达3倍(<0.001)。
提取物有潜力用作改善胰岛素抵抗的抗糖尿病药物,可能是通过增加mtDNA含量来实现。